Moore Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Hold
0
485
2023
Q4
Sell
-20,400
Closed -$2.47M 487
2023
Q3
$2.47M Buy
+20,400
New +$2.47M 0.05% 193
2023
Q2
Sell
-116,819
Closed -$16.1M 548
2023
Q1
$16.1M Buy
116,819
+98,789
+548% +$13.6M 0.34% 44
2022
Q4
$2.34M Sell
18,030
-162,030
-90% -$21M 0.06% 240
2022
Q3
$19.9M Buy
180,060
+99,760
+124% +$11M 0.47% 30
2022
Q2
$6.02M Buy
80,300
+51,622
+180% +$3.87M 0.16% 126
2022
Q1
$2.24M Buy
+28,678
New +$2.24M 0.06% 337
2019
Q2
Sell
-7,750
Closed -$924K 356
2019
Q1
$924K Sell
7,750
-4,803
-38% -$573K 0.03% 226
2018
Q4
$1.37M Buy
12,553
+7,553
+151% +$824K 0.05% 151
2018
Q3
$808K Sell
5,000
-4,000
-44% -$646K 0.02% 204
2018
Q2
$1.19M Buy
+9,000
New +$1.19M 0.03% 179
2016
Q4
Sell
-70,000
Closed -$4.3M 259
2016
Q3
$4.3M Buy
+70,000
New +$4.3M 0.15% 89